1.61BMarket Cap-186000P/E (TTM)
22.480High21.935Low163.93KVolume22.100Open22.040Pre Close3.65MTurnover0.97%Turnover Ratio111.60P/E (Static)72.20MShares28.15052wk High3.69P/B376.29MFloat Cap16.47052wk Low--Dividend TTM16.86MShs Float32.880Historical High--Div YieldTTM2.47%Amplitude5.010Historical Low22.267Avg Price1Lot Size
Kiniksa Pharmaceuticals International Stock Forum
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2 ...
i) Current market- $SPDR S&P 500 ETF (SPY.US)$
ii) Oil price
iii) My trade based on stage analysis
i) To be honest, after the last month CPI showed that the inflation is still not under controlled, the big sell off volume ha...
No comment yet